RxDoctor Payments Data

Gregory Golladay, MD

Orthopaedic Surgery · Richmond, VANPI 1780672824

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $32,626 of the $52,066 with a category attached, or 62.7%. Orthosensor Inc. accounts for 84.5% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $41,654 and has fallen 99.6% since, to $159 in 2025.

$52,066in general payments, 2019–2025

Across 27 payments — averaging $1928.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Orthosensor Inc.$44K
  • Stryker$8K
  • Medtronic$147
  • Smith+Nephew$144
  • Johnson & Johnson$110
  • Zimmer Biomet$30
  • plus $24 from 1 others
$53,114in research payments, 2019–2025

Across 13 payments — averaging $4085.68 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Orthosensor Inc.$34K
  • KCI USA, Inc.$19K

What the payments were for

  • Royalty or licence$32,62663%
  • Consulting fees$18,36335%
  • Travel & lodging$180%
  • Food & beverage$1,0592%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Orthosensor Inc.10$44,007
Stryker10$7,604
Medtronic3$147
Smith+Nephew1$144
Johnson & Johnson1$110
Zimmer Biomet1$30
Abbott1$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$52,066 in reported general payments places this provider in the 85th percentile of 473 orthopaedic surgery providers in Virginia.

See all orthopaedic surgery providers in Virginia

Medicare billing

Part B allowed, 2024
$266,878
Medicare patients
664
Services billed
1,660

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl49$287
Gabapentin34$277
Diclofenac Sodium13$191
Methylprednisolone22$111
Tramadol Hcl27$66
Meloxicam38$50
Cephalexin14$41
Alendronate Sodium13$21
Amoxicillin13$7

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Richmond

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →